Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759]

<p>Abstract</p> <p>After surgical intervention with curative intention in specialised centres the five-year survival of patients with carcinoma of the exocrine pancreas is only 15%. The ESPAC-1 trial showed an increased five-year survival of 21% achieved with adjuvant chemotherapy....

Full description

Bibliographic Details
Main Authors: Schmitz-Winnenthal H, Lindel K, Seiler C, Hoffmann K, Schmidt J, Märten A, Knaebel HP, Fritz S, Herrmann T, Goldschmidt H, Krempien R, Mansmann U, Debus J, Diehl V, Büchler MW
Format: Article
Language:English
Published: BMC 2005-04-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/5/37

Internet

http://www.biomedcentral.com/1471-2407/5/37

Similar Items